MLEC
Price
$1.21
Change
-$0.06 (-4.72%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
13.83M
40 days until earnings call
SPRB
Price
$9.52
Change
-$0.06 (-0.63%)
Updated
Sep 17, 04:58 PM (EDT)
Capitalization
3.32M
Interact to see
Advertisement

MLEC vs SPRB

Header iconMLEC vs SPRB Comparison
Open Charts MLEC vs SPRBBanner chart's image
Moolec Science SA
Price$1.21
Change-$0.06 (-4.72%)
Volume$1.84K
Capitalization13.83M
Spruce Biosciences
Price$9.52
Change-$0.06 (-0.63%)
Volume$500
Capitalization3.32M
MLEC vs SPRB Comparison Chart in %
Loading...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.89B. The market cap for tickers in the group ranges from 58 to 100.34B. VRTX holds the highest valuation in this group at 100.34B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 35%. NDTP experienced the highest price growth at 1,681%, while ATYR experienced the biggest fall at -80%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 86%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was 46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 82
Price Growth Rating: 57
SMR Rating: 93
Profit Risk Rating: 94
Seasonality Score: -22 (-100 ... +100)

Market Cap

The average market capitalization across the group is 13.83M. The market cap for tickers in the group ranges from 13.83M to 13.83M. MLEC holds the highest valuation in this group at 13.83M. The lowest valued company is MLEC at 13.83M.

High and low price notable news

The average weekly price growth across all stocks in the group was 8%. For the same group, the average monthly price growth was -48%, and the average quarterly price growth was -82%. MLEC experienced the highest price growth at 8%, while MLEC experienced the biggest fall at 8%.

Volume

The average weekly volume growth across all stocks in the group was 63%. For the same stocks of the group, the average monthly volume growth was 503% and the average quarterly volume growth was 4,524%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 43
P/E Growth Rating: 100
Price Growth Rating: 98
SMR Rating: 99
Profit Risk Rating: 100
Seasonality Score: (-100 ... +100)
VS
MLEC vs. SPRB commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLEC is a Buy and SPRB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (MLEC: $1.21 vs. SPRB: $9.58)
Brand notoriety: MLEC and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLEC: 19% vs. SPRB: 220%
Market capitalization -- MLEC: $13.83M vs. SPRB: $3.32M
MLEC [@Biotechnology] is valued at $13.83M. SPRB’s [@Biotechnology] market capitalization is $3.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLEC’s FA Score shows that 0 FA rating(s) are green whileSPRB’s FA Score has 1 green FA rating(s).

  • MLEC’s FA Score: 0 green, 5 red.
  • SPRB’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRB is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLEC’s TA Score shows that 5 TA indicator(s) are bullish.

  • MLEC’s TA Score: 5 bullish, 3 bearish.

Price Growth

MLEC (@Biotechnology) experienced а -2.42% price change this week, while SPRB (@Biotechnology) price change was -1.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

MLEC is expected to report earnings on Oct 27, 2025.

SPRB is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLEC($13.8M) has a higher market cap than SPRB($3.32M). SPRB YTD gains are higher at: -69.587 vs. MLEC (-84.875).
MLECSPRBMLEC / SPRB
Capitalization13.8M3.32M416%
EBITDA-5.24MN/A-
Gain YTD-84.875-69.587122%
P/E RatioN/AN/A-
Revenue7.83MN/A-
Total Cash926KN/A-
Total Debt22.1MN/A-
TECHNICAL ANALYSIS
Technical Analysis
MLEC
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
47%
Momentum
ODDS (%)
Bullish Trend 2 days ago
47%
MACD
ODDS (%)
Bullish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
38%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
60%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA425.864.24
+1.01%
Tesla
AAPL238.990.84
+0.35%
Apple
SPY659.18-0.82
-0.12%
SPDR® S&P 500® ETF
BTC.X116468.510000-374.679700
-0.32%
Bitcoin cryptocurrency
GME26.10-0.24
-0.91%
GameStop Corp

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with SPRB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
-4.72%
SPRB - MLEC
51%
Loosely correlated
N/A
CTMX - MLEC
42%
Loosely correlated
-1.28%
AAVXF - MLEC
38%
Loosely correlated
N/A
ABEO - MLEC
36%
Loosely correlated
-0.79%
ABVC - MLEC
31%
Poorly correlated
+0.86%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with MTVA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
N/A
MTVA - SPRB
61%
Loosely correlated
-20.30%
IMRX - SPRB
52%
Loosely correlated
-3.01%
MLEC - SPRB
51%
Loosely correlated
-4.72%
GNFT - SPRB
39%
Loosely correlated
-1.74%
IMCR - SPRB
37%
Loosely correlated
-1.26%
More